Bone Biologics Co. (NASDAQ:BBLGW – Get Free Report)’s stock price shot up 10.8% during mid-day trading on Friday . The stock traded as high as $44.30 and last traded at $44.30. 809 shares traded hands during trading, a decline of 66% from the average session volume of 2,400 shares. The stock had previously closed at $40.00.
Bone Biologics Stock Up 10.8 %
The firm has a fifty day moving average price of $29.88 and a two-hundred day moving average price of $46.95.
About Bone Biologics
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1.
Read More
- Five stocks we like better than Bone Biologics
- 3 Best Fintech Stocks for a Portfolio Boost
- Insiders Are Selling, But These 3 Stocks Are Must-Buys
- Buy P&G Now, Before It Sets A New All-Time High
- Rivian Defies Doubters: Delivery Triumph Fuels Stock Surge
- What is Insider Trading? What You Can Learn from Insider Trading
- Hindenburg Short Report Slams Carvana Over Alleged ‘Grift’
Receive News & Ratings for Bone Biologics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bone Biologics and related companies with MarketBeat.com's FREE daily email newsletter.
